NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 31 min ago

Addressing Mental Health Disparities Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01 Clinical Trial Not Allowed)

Fri, 2022-03-11 11:47
Funding Opportunity RFA-MH-22-200 from the NIH Guide for Grants and Contracts. This initiative seeks to foster research targeting the reduction and elimination of mental health disparities by racial and ethnic groups, geographical settings, and socioeconomic status in the United States. It solicits research projects using the R01 mechanism to aggregate and examine existing data sets to increase understanding of mental health disparities and how to intervene to reduce mental health disparities and achieve mental health equity across the lifespan. This includes examining: 1) factors that contribute to, exacerbate and reduce disparities at multiple levels (e.g., policy, community, school, family, individual) at different developmental stages; 2) etiology and trajectories; and 3) prevention and treatment interventions and services and their implementation and dissemination. NIH-designated U.S. health disparity populations include Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities (NOT-OD-15-089).

Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)

Fri, 2022-03-11 02:19
Funding Opportunity PAR-22-104 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is a reissue due to an omission of TRAINING RECORD review questions in Section V. This FOA encourages applications for the Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) D43 program for institutional research training programs in low-and middle-income countries (LMICs, as defined by the World Bank classification system). Applications may be for collaborations between institutions in the U.S and an eligible LMIC or may involve just LMIC institutions if there is a previous track record of externally funded research and/or research training programs by the lead LMIC institution. The proposed institutional research training program is expected to sustainably strengthen the NCD research capacity of the LMIC institutions, and to train in-country experts to develop and conduct research on NCDs across the lifespan, with the long-range goal of developing and implementing evidence-based interventions relevant to their countries. The main focus of research training covered in the application must be relevant to the interests of at least one of the participating NIH ICs as stated by each in this FOA. Other NCD topics may be included as secondary and complementary focus areas. This Funding Opportunity Announcement (FOA) allows support of trainees as the lead investigator of an independent clinical trial; or a separate ancillary study to an existing trial; or to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed)

Fri, 2022-03-11 01:59
Funding Opportunity RFA-AI-22-019 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support pandemic preparedness by providing an opportunity for facility improvements and building systems upgrades at existing BSL3 and BSL4 biocontainment laboratories engaged in research on RNA viruses of pandemic potential to facilitate the conduct of biomedical research on vaccines and therapeutics.

Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)

Thu, 2022-03-10 10:06
Funding Opportunity RFA-AI-22-022 from the NIH Guide for Grants and Contracts. This funding opportunity will support high risk, milestone-driven research for the development of innovative assays designed to enable the measurement of HIV susceptibility to broadly neutralizing antibodies (bNAbs) in clinical laboratories. Proposed studies should target early-stage assay development and demonstrate feasibility and clinical utility, followed by verification and late stage validation of the method. Collaborative, interdisciplinary research with partnerships between academia and industry is strongly encouraged.

NIA Program Project Applications (P01 Clinical Trial Optional)

Thu, 2022-03-10 09:56
Funding Opportunity PAR-22-130 from the NIH Guide for Grants and Contracts. The National Institute on Aging (NIA) invites the submission of investigator-initiated research program project (P01) applications addressing scientific areas relevant to NIA's mission. Each application submitted to this Funding opportunity announcement (FOA) must include at least three related research projects that share a common central theme, focus, overall objective, and an administrative core to lead the project.?Revision applications should include expansion of an existing, or proposal of a new, project(s) within the context and theme of the parent P01 award. Revision applications may not request support beyond the end date of the parent P01 award, but may propose to expand existing cores, or propose new cores, to support the expansion or creation of new projects.

International Bioethics Research Training Program (D43 Clinical Trial Optional)

Thu, 2022-03-10 04:05
Funding Opportunity PAR-22-116 from the NIH Guide for Grants and Contracts. FIC will support LMIC-U.S. collaborative institutional bioethics doctoral and postdoctoral research training programs that incorporate didactic, mentored research and training components to prepare multiple individuals with ethics expertise for positions of scholarship and leadership in health research institutions in the LMIC.

International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)

Thu, 2022-03-10 03:58
Funding Opportunity PAR-22-118 from the NIH Guide for Grants and Contracts. Education programs supported by this initiative will equip scientists, health professionals and academics in low and middle-income countries with in-depth knowledge of the ethical principles, processes and policies related to international clinical and public health research.

Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)

Tue, 2022-03-08 10:33
Funding Opportunity PAR-22-107 from the NIH Guide for Grants and Contracts. The Centers of Excellence in Genomic Science (CEGS) program establishes academic Centers for advanced genome research. Each CEGS award supports a multi-investigator, interdisciplinary team to develop transformative genomic approaches to address a biomedical problem. A CEGS project will address a critical issue in genomic science, genomic medicine, or computational genomics, proposing a highly innovative solution that would be a major advance. The research will entail substantial risk, balanced by outstanding scientific and management plans and very high potential payoff. A CEGS will focus on the development of novel technological or computational methods for the production or analysis of comprehensive data sets, on a genome-scale biomedical problem, or on other ways to develop and use genomic approaches for understanding biological systems or furthering the application of genomic knowledge, data, and methods towards clinical applications. Each CEGS will nurture genomics at its institution by facilitating the interaction of investigators from several disciplines. By training new and experienced investigators it will expand the pool of genomics scientists and engineers.

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Tue, 2022-03-08 10:24
Funding Opportunity PAR-22-123 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years.

2022 NIAID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2022-1 Now Available

Tue, 2022-03-08 10:10
Notice NOT-AI-22-039 from the NIH Guide for Grants and Contracts

Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)

Tue, 2022-03-08 10:05
Funding Opportunity RFA-CA-22-015 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide resources to support the time and effort of transdisciplinary teams in collaboration with communities and clinics to develop a cancer prevention and control research program and provide training to junior investigators that focuses on and serves populations in persistent poverty. The long-term goal of this initiative is to build capacity in persistent poverty areas to foster cancer prevention and control research and promote the implementation of programs and practices in communities to alleviate the effects of persistent poverty.

Pages